Evidence map›Paper›PMID 37631244›Full record

ArticlePharmaceutics2023

Therapeutic Salivary Monitoring of Perampanel in Patients with Epilepsy Using a Volumetric Absorptive Microsampling Technique.

Michela Palmisani, Elena Tartara, Cecilie Johannessen Landmark, Francesca Crema, Valentina De Giorgis, Costanza Varesio, Cinzia Fattore, Paola Rota, Emilio Russo, Valentina Franco

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Modern Analytical Techniques in Epilepsy Research.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Michela PalmisaniClinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Elena TartaraEpilepsy Center, ERN Network EpiCare, IRCCS Mondino Foundation, 27100 Pavia, Italy.
Cecilie Johannessen LandmarkDepartment of Pharmacy, Faculty of Health Sciences, Oslo Metropolitan University, 0316 Oslo, Norway.ORCID 0000-0002-0877-8912
Francesca CremaClinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
Valentina De GiorgisDepartment of Child Neurology and Psychiatry, ERN Network EpiCare, IRCCS Mondino Foundation, 27100 Pavia, Italy.ORCID 0000-0002-5828-7070
Costanza VaresioDepartment of Child Neurology and Psychiatry, ERN Network EpiCare, IRCCS Mondino Foundation, 27100 Pavia, Italy.ORCID 0000-0001-5645-021X
Cinzia FattoreIRCCS Mondino Foundation, 27100 Pavia, Italy.
Paola RotaDepartment of Biomedical, Surgical and Dental Sciences, University of Milan, 20100 Milan, Italy.ORCID 0000-0001-5795-4989
Emilio RussoScience of Health Department, School of Medicine and Surgery, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy.ORCID 0000-0002-1279-8123
Valentina FrancoClinical and Experimental Pharmacology Unit, Department of Internal Medicine and Therapeutics, University of Pavia, 27100 Pavia, Italy.
University of Pavia · ITMagna Graecia University · ITOslo University Hospital · NOUniversity of Milan · IT

Funding

Italian Ministry of Health Ricerca Corrente, IRCCS Mondino Foundation, Pavia, Italy
6 · The paper itself

Abstract

The objective of this study was to validate a novel assay using the volumetric absorptive microsampling (VAMS) technique combined with liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) for the determination of the antiseizure medication perampanel in saliva and its clinical applicability in patients with epilepsy. VAMS tips were loaded with 30 μL of saliva and dried for 60 min. Analytes were extracted with methanol. The supernatant was evaporated under a gentle stream of nitrogen and reconstituted with 60 μL of methanol. Separation and quantification were achieved on a monolithic column connected to a mass spectrometer. Calibration curves were linear between 0.5 and 300 ng/mL. Intra- and inter-day accuracy was within 85.6-103.2% and intra-day and inter-day precision did not exceed 12.1%. Perampanel was stable in samples collected by VAMS and stored under different storage conditions. The VAMS-LC-MS/MS method was validated according to internationally accepted criteria and tested in patients with epilepsy who were receiving a combination of perampanel and other antiseizure medications. The method showed adequate bioanalytical performances, holding great potential as an alternative strategy to support domiciliary TDM in patients with epilepsy treated with perampanel according to the simplicity of sample collection.

Indexed as

LC-MS/MSperampanelsalivatherapeutic drug monitoringvolumetric absorptive microsampling

Identifiers

PMID37631244
PMCPMC10458119
OpenAlexW4385347966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.